Member Info for appletree1

Interesting that the delayed 2.5M trade at 1.096p from mid-day yesterday was clearly yet another buy at that time and there are no delayed sells from yesterday, reinforcing the view that the drop in SP is primarily due to the MMs exploiting the wider market jitters this week to facilitate cheap negotiated buys and encourage greater volume trading. Again today the sells don't out-weigh buys. The SP dip isn't warranted by the level of selling. I read this as a cyclical drop by the MMs to the stock's IPO price and the next move of any size should be the return to upwards trajectory. The Fed's final press conference of the year this evening was well-received so the broader global market down-pressure that was building this week should ease a bit. The NASDAQ relief rally is at 2.2% just now. We just need to get a bit of renewed focus on this stock and it should be in for a strong bounce. With New Year portfolio adjustments coming up it would be great to get some more publicity/ news to coincide.

Now that we know Affidx works for Omicron the chances of it getting allowance and sooner rather than later has improved significantly IMHO. Traders will always try to scalp/sell on news and then try to talk the share down so they can rinse and repeat. The stock has definitely become more investment worthy today not less.

Given the number of sizeable rounded 100k, 500k 1M buys at 1.05p at the moment and the heavy-handed way that the SP was walked down to that level and is being repeatedly restrained to that level despite the buys it looks to me suspiciously like the MMs have done this to order, to allow one or more block buyers to load up on the cheap.

MMs rather heavy-handed on the tree shaking running the SP down 10% this morning on a few paltry sells totaling a mere 30k pounds. On the same basis it shouldn't take much of a rise in interest in the stock for the SP to recover very quickly. A bit of news and renewed publicity at this bargain level should grab attention and bring new investors in. At the moment a lot of the AIM action is unsurprisingly focused on rotating between the Covid stocks, but when that diminishes, as it inevitably will, no doubt some will return to the undervalued GPM stocks. The New Year portfolio adjustments in two weeks time may well bring further uplift.

Nice to see that we actually touched 30p on the book offer price (29.5p paid) this afternoon (52 week high) and ended blue despite the broader market's woes. As Jlite observed, the SP here continues to show what looks like an engineered dip in the morning followed by a rise around 2PM and it has been yo-yoing daily like that with a clear overall uptrend over the last week. Quite possibly the up-trend will continue the rise to 30p and over very soon without needing any fresh news. The SP is still way below peer valuations and it could easily rise further as the stock comes to the attention of more investors here and in the US. I suspect that New Year portfolio adjustments could also bring more investors over to this stock in the next three weeks since this stock is very much thematically 'on-trend' and logically the SP here should continue to rise over the coming year as we get closer and closer to the predicted start of production.

Diversification is key. Masks sell much better when and where mask-wearing is at least advisory and best when/where it is mandatory. Good viral control HVAC filters, by contrast, are consumables that will continue to sell well universally and at any time and don't rely on pandemics and Government advice/controls to sell well. So : - the realization of this expanding/diversifying business model should make NNN much more worthy of investment now and as it progresses.

Waynesmith, as you can see from the RNSes, the Volz connection to date has been relatively informal and was basically limited to supporting the mask side of the business . Clearly the market ceased to be interested in the mask side of the business this Summer, not least because mask wearing became optional in the UK over the Summer - hence the poor performance of this share leading to it plumbing the recent lows of 0.6p. Although the 25 June RNS mentioned in passing Volz's interest in collaborating on other projects with NNN including HVAC usages, the market clearly didn't take notice of that at the time or take it as any kind of commitment. Today's news of the signed JV agreement is a step-change that the market now sees and acknowledges. Clearly now Volz are seen to be committing to bringing to bear their considerable expertise in their existing core market in joint venture with NNN. In my opinion there is a much greater chance of NNN making serious revenue on this project than they have ever had with the masks and if anyone can help make a success of it Volz will. The cost/benefit argument and potential for take up of NNNs tech is in my opinion likely to be much stronger in the HVAC context than it is/was with the masks. Unlike the fickle, cheapskate mass of the mask-buying public (me included), corporate HVAC customers are much more likely to be discriminating and take safety seriously into consideration and not baulk at the relatively small extra expense to buy advanced HVAC filters to provide better viral control.

The closing group of trades today look very bullish, with no noticeable end of day dip. There were seven buys at 1.19p and a couple of modest sells at 1.16p just prior to close. The 1.05p UT that followed them is clearly anomalous - a single mere 1.65 k trade at nearly 10% below the bid reads to me as one person getting mugged on his rushed closing sell.

Nice of the MMs to walk it down to 25.18p for top-ups this morning. IMHO If the lead time to start of production is likely being cut to under 2 years or so then the SP really shouldn't be as vulnerable to retracing in the way it was earlier this year when we were expecting a four year wait to production. Also it doesn't yet look like the reduced lead time mentioned by the MD has been priced into the SP yet. If the expedited time-frame hasn't yet been formally notified to the market then perhaps when it is formally mentioned in any forthcoming RNS we should see a serious sustained further upswing. (As others including the MD have mentioned, we are way behind Lithium mining peers on valuation, and that is presumably in large part due to the previously assumed larger gap to our production start (and hence the logical disconnect from the year's increase in Lithium price), but since the gap to production is now likely to be much smaller the SP should gain to reflect that and at least partially reflect the increased Lithium value.

Quite a lot of boards on this web-site are plagued by one resident troll with multiple accounts. I wouldn't be surprised if this pair of toad accounts isn't just the machinations of a single delightful individual.

Broker note update today proposes updated target price 4.2p fully diluted.

A special dividend to Pembridge share-holders corresponding to the sale of the asset/ Minto share-holding (eg near to 13p to 14p divi per Pembridge share currently) is indeed a plausible option. It might well be the outcome here. It is what several companies in a similar position have done and would likely be acceptable to the majority of share-holders here, including our major share-holder / Managing Director - especially if the SP here otherwise continues to sit at this discounted level. Before we reach that point, however, it would be good to hear what Gati's current plans for the businesses are and to see if we can feasibly get to the 14p SP level here reasonably soon without divesting the Minto share-holding.

This drop back to 6p, around the average SP level of the last year, is on very small volume. This stock is of course majorly under-valued currently. The TSX listing proves that. Paradoxically since that hasn't led to an immediate upwards re-rate the impatient have accordingly sold/are slowly selling and the LTH's are refraining from topping up until fresh investors spot this stock and buy in. I think we need exposure / a further catalyst to grab the broader market's attention. As a starting point I think Gati should do stock-market publicity interviews on VOX etc and set out the achievements, prospective revenues and his vision/plans for Minto and Pembridge.

Pseudo ; - Most of the time on AIM you are buying indirectly (not off-book directly from the person selling the stock) so you don't get your buy and the seller's sell reported simultaneously. The MMs have control over the share-price and can easily give false signals, delay reporting large trades, tree-shake or skew the mid-price to mask the overall direction of travel of a stock's share price within a day. Knowing which trades are buys rather than sells (and when they occurred) matters if you want to have a clearer idea of what is really happening to the SP of a volatile stock to time your buys or sells optimally. You can, for example, better gauge when the pump and dump crew/trader herd have hit the top of their latest engineered spike and are starting to sell the stock down again (which is very relevant to all the Covid stocks currently as they are successively hit by the crews/trader herd).

I don't think there would be much short volume on GDR at this low price level and it shouldnt make much difference to price action. There is no indication that any of the big hedge funds have ever shorted GDR above the 0.5% shorting notificaton thresh-hold , but as with many other stocks the down-swings were probably exacerbated by shorting crews. (On AIM among other covid/pharma stocks Novacyt, Avacta and 4D Pharma all have hedge fund shorters that cyclically attack them).

Most or all stocks on Aim can be shorted and are shorted. AFAIK, the only UK market that is legally protected from shorting is AQUIS.

Penny, is GDR really ineligible for shorting? On what basis do you make that assertion?

This spike was a herd-driven surge. (I don't think you can call it a 'Pump and Dump' when no-one was actually talking the stock up - but perhaps that is just semantics). These surges occur mostly because there are currently many disillusioned AIM stock investor/traders who have given up sticking with stocks and are rainbow-chasing sequentially through them, and especially through the zeitgeist Covid stocks at the moment. Of course it is not a coincidence that as one stock rises and then drops back another stock then rises and so on. Stock-specific news is not a pre-requisite when a stock has already fallen massively and is probably substantially under-valued like this one. On this occasion much of the hot money will almost certainly have come from the preceding Genedrive rise (and previously Avacta gained temporarily at Novacyt's expense etc, etc) . Some of the surge rise is likely to stick in each case, so there is some gain for the long-suffering loyal investors, but these spikes are still a hazard for any unwary investors who top-up into the rise rather than before-hand.

A few impatient traders selling out have dipped the price temporarily but as a sterling proxy for MINTO, following Minto's successful IPO in Canada currently this stock is now considerably undervalued and it should in time rise to fair value once the impatient traders have moved on.
In the words of Gati Al-Jebouri, Chief Executive Officer and Chairman of the Board of Pembridge regarding the Pembridge raise for funding Minto in September:

"This capital raise by Minto Metals, resulting in investment by new and existing shareholders at a pre-money valuation of CAD$ 156.6 million, confirms the true value of our investment in Minto. This additional capital will enable Minto Metals to further increase production, to benefit from the resulting economies of scale as well as the current strong price of copper and to extend its life of mine with further exploration. The capital raise and listing of Minto Metals provides a transparent third party valuation of our investment. I trust that the market will now recognise the value of Pembridge's investment and reflect this in the Company's market valuation. We are proud to have been involved in re-starting the mine and pleased that it is now able to move into a new phase of development with the upcoming listing and new capital and look forward to seeing the value of our investment increase as Minto Metals delivers on its long term objectives. With the expected cash inflows from Minto Metals and higher valuation of our company, I believe that we will be ready to execute on the fourth stage of Pembridge development, which I outlined in 2019 when I took over the leadership of the company. This stage is the identification of new projects to invest in and grow our business."

The SP was dipped below the 1.20p bid today by the MMs on very little visible selling (only about 1.5M shares sold - ie only about 17,000 pounds). On the face of it the MMs simply dipped the SP, exploiting the FTSE drop, to facilitate negotiated buys and to encourage further buying volume. There were about four times as many buys (6.3M) as reported sells (1.5M) today, though possibly there is also a worked sell/ delayed sell (or worked buy) not yet showing that will be reported tomorrow. On the face of it the SP should be just on the verge of bouncing back over the 1.20p bid level. [We saw the 1.15 bid level briefly intra-day last week too and there isn't any serious selling pressure then or now at that level ]. In addition to the technical support for the SP at this level, we are on the cusp of receiving important updates that should trigger a substantial rapid upwards re-rate of the SP.